We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Top Buys

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$6.48M
2
AMK
AssetMark Financial Holdings, Inc.
AMK
+$6.21M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$6.05M
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$5.93M
5
FTRE icon
Fortrea Holdings
FTRE
+$5.34M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$16.5M
2
NVDA icon
NVIDIA
NVDA
+$13.1M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.16M
4
VIPS icon
Vipshop
VIPS
+$8.72M
5
CSTR
CapStar Financial Holdings, Inc
CSTR
+$8.17M

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTH icon
1376
Life Time Group Holdings
LTH
$9.79B
– –
-10,862
Closed -$169K
LYEL icon
1377
Lyell Immunopharma
LYEL
$360M
– –
-1,265
Closed -$56.4K
LYRA
1378
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-308
Closed -$95.8K
MAR icon
1379
Marriott International
MAR
$92.3B
– –
-902
Closed -$228K
MAS icon
1380
Masco
MAS
$15.3B
– –
-3,554
Closed -$280K
MAT icon
1381
Mattel
MAT
$4.23B
– –
-30,934
Closed -$613K
MATX icon
1382
Matsons
MATX
$6.18B
– –
-5,640
Closed -$634K
MCHI icon
1383
iShares MSCI China ETF
MCHI
$6.38B
– –
-50,000
Closed -$1.99M
MCRB icon
1384
Seres Therapeutics
MCRB
$48.4M
– –
-3,530
Closed -$54.6K
MDB icon
1385
MongoDB
MDB
$32.1B
– –
-4,187
Closed -$1.5M
MDT icon
1386
Medtronic
MDT
$112B
– –
-45,942
Closed -$4M
MGA icon
1387
Magna International
MGA
$18.8B
– –
-10,584
Closed -$577K
MIDD icon
1388
Middleby
MIDD
$6.08B
– –
-2,605
Closed -$419K
MLTX icon
1389
MoonLake Immunotherapeutics
MLTX
$1.55B
– –
-4,149
Closed -$208K
MMM icon
1390
3M
MMM
$94.3B
– –
-7,689
Closed -$682K
MNSO icon
1391
MINISO
MNSO
$3.75B
– –
-9,912
Closed -$203K
MOD icon
1392
Modine Manufacturing
MOD
$10.4B
– –
-2,143
Closed -$204K
MPC icon
1393
Marathon Petroleum
MPC
$83.7B
– –
-1,517
Closed -$306K
MSOS icon
1394
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
– –
-12,193
Closed -$122K
MU icon
1395
CALL
Micron Technology
MU
$991B
– –
-10,000
Closed -$1.18M
MUSA icon
1396
Murphy USA
MUSA
$9.61B
– –
-866
Closed -$363K
NAT icon
1397
Nordic American Tanker
NAT
$1.37B
– –
-10,430
Closed -$40.9K
NDSN icon
1398
Nordson
NDSN
$17.3B
– –
-1,893
Closed -$520K
NET icon
1399
Cloudflare
NET
$107B
– –
-2,125
Closed -$206K
NEU icon
1400
NewMarket
NEU
$8.18B
– –
-581
Closed -$369K
54 55
56
57 58

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.